DK140281B - Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-cycloalkylaminopropaner eller syreadditionssalte heraf. - Google Patents

Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-cycloalkylaminopropaner eller syreadditionssalte heraf.

Info

Publication number
DK140281B
DK140281B DK380170AA DK380170A DK140281B DK 140281 B DK140281 B DK 140281B DK 380170A A DK380170A A DK 380170AA DK 380170 A DK380170 A DK 380170A DK 140281 B DK140281 B DK 140281B
Authority
DK
Denmark
Prior art keywords
cycloalkylaminopropanes
racemic
phenoxy
hydroxy
preparation
Prior art date
Application number
DK380170AA
Other languages
Danish (da)
English (en)
Other versions
DK140281C (xx
Inventor
Herbert Koeppe
Werner Kummer
Helmut Staehle
Karl Zeile
Albrecht Engelhardt
Werner Traunecker
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of DK140281B publication Critical patent/DK140281B/da
Application granted granted Critical
Publication of DK140281C publication Critical patent/DK140281C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/53—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04H—BUILDINGS OR LIKE STRUCTURES FOR PARTICULAR PURPOSES; SWIMMING OR SPLASH BATHS OR POOLS; MASTS; FENCING; TENTS OR CANOPIES, IN GENERAL
    • E04H13/00—Monuments; Tombs; Burial vaults; Columbaria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Architecture (AREA)
  • Structural Engineering (AREA)
  • Civil Engineering (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK380170AA 1969-07-23 1970-07-22 Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-cycloalkylaminopropaner eller syreadditionssalte heraf. DK140281B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1937477A DE1937477C3 (de) 1969-07-23 1969-07-23 I -Phenoxy-2-hydroxy-3-(l -methylcycloalkylamino)-propane, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
DK140281B true DK140281B (da) 1979-07-23
DK140281C DK140281C (xx) 1979-12-10

Family

ID=5740681

Family Applications (1)

Application Number Title Priority Date Filing Date
DK380170AA DK140281B (da) 1969-07-23 1970-07-22 Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-cycloalkylaminopropaner eller syreadditionssalte heraf.

Country Status (17)

Country Link
US (1) US3755413A (xx)
JP (5) JPS5133106B1 (xx)
AT (9) AT304474B (xx)
BE (1) BE753774A (xx)
BG (9) BG17508A3 (xx)
CH (10) CH570363A5 (xx)
CS (9) CS170524B2 (xx)
DE (1) DE1937477C3 (xx)
DK (1) DK140281B (xx)
ES (8) ES382014A1 (xx)
FR (1) FR2059551B1 (xx)
GB (1) GB1314896A (xx)
NL (1) NL169874C (xx)
PL (9) PL79772B1 (xx)
RO (9) RO59159A (xx)
SE (1) SE370391B (xx)
YU (5) YU34395B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937706A (en) * 1969-07-23 1976-02-10 Boehringer Ingelheim Gmbh 1-(2'ethynyl-phenoxy)-2-hydroxy-3-(cycloalkyl-amino)-propanes and salts thereof
US4021576A (en) * 1969-07-23 1977-05-03 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing a 1-(2'-ethynyl-phenoxy)-2-hydroxy-3-(cycloalkyl-amino)-propane and method of use
US4038313A (en) * 1970-01-08 1977-07-26 Ciba-Geigy Corporation Cycloalkylureido phenoxy propanolamines
US4120978A (en) * 1970-01-08 1978-10-17 Ciba-Geigy Corporation Pharmaceutical composition for inhibiting and blocking cardioselective beta-receptors
SE354851B (xx) * 1970-02-18 1973-03-26 Haessle Ab
US4145442A (en) * 1972-04-04 1979-03-20 Aktiebolaget Hassle Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases
US4038414A (en) * 1972-06-08 1977-07-26 Ciba-Geigy Corporation Amines and processes for their manufacture
US4035420A (en) * 1972-07-06 1977-07-12 Aktiebolaget Hassle Substituted ureido alkylene phenoxy propanolamines
DE2309887C2 (de) * 1973-02-28 1983-11-10 C.H. Boehringer Sohn, 6507 Ingelheim 1-Aryloxy-2-hydroxy-3-alkinylaminopropan-Derivate und deren physiologisch verträgliche Säureadditionssalze, pharmazeutische Präparate und Herstellungsverfahren für die Verbindungen
US4220659A (en) * 1974-02-22 1980-09-02 Boehringer Ingelheim Gmbh 1-Phenoxy-2-hydroxy-3-alkynylamino-propanes and salts thereof
SE7510153L (sv) * 1974-09-12 1976-05-07 American Cyanamid Co Alkanolaminer
US4165384A (en) * 1974-11-01 1979-08-21 Aktiebolaget Hassle Amide substituted phenoxy propanol amines
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4471127A (en) * 1981-09-08 1984-09-11 Ciba-Geigy Corporation 1-5-Bis-(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols
US5039801A (en) * 1985-12-20 1991-08-13 The United States Of America As Represented By The Department Of Health & Human Services Thermal fragmentation of methylbenzylurea disastereomers or secondary amines and preparation of optically active secondary amines
JPS6364630U (xx) * 1986-10-17 1988-04-28

Also Published As

Publication number Publication date
CS170524B2 (xx) 1976-08-27
PL90026B1 (xx) 1976-12-31
NL169874B (nl) 1982-04-01
CS170525B2 (xx) 1976-08-27
YU34663B (en) 1979-12-31
YU34396B (en) 1979-07-10
YU34395B (en) 1979-07-10
AT304477B (de) 1973-01-10
RO59210A (xx) 1976-01-15
PL79772B1 (xx) 1975-06-30
BG17505A3 (bg) 1973-11-10
CH537360A (de) 1973-05-31
US3755413A (en) 1973-08-28
YU255175A (en) 1978-06-30
BG17507A3 (bg) 1973-11-10
YU254575A (en) 1979-04-30
JPS5210862B1 (xx) 1977-03-26
CH536811A (de) 1973-06-29
CH536809A (de) 1973-06-29
DE1937477C3 (de) 1980-04-10
BG19132A3 (bg) 1975-04-30
YU186070A (en) 1978-12-31
BG17751A3 (bg) 1973-12-25
PL90028B1 (xx) 1976-12-31
NL7010928A (xx) 1971-01-26
JPS5210863B1 (xx) 1977-03-26
AT306702B (de) 1973-04-25
AT304476B (de) 1973-01-10
FR2059551B1 (xx) 1974-09-20
SE370391B (xx) 1974-10-14
CH536813A (de) 1973-06-29
AT306704B (de) 1973-04-25
BG17506A3 (bg) 1973-11-10
CH570363A5 (xx) 1975-12-15
AT304478B (de) 1973-01-10
RO59089A (xx) 1975-11-15
BG17749A3 (bg) 1973-12-25
YU254475A (en) 1978-12-31
ES394913A1 (es) 1974-12-16
CS170527B2 (xx) 1976-08-27
JPS5133106B1 (xx) 1976-09-17
RO59159A (xx) 1976-02-15
YU34662B (en) 1979-12-31
AT306703B (de) 1973-04-25
PL90039B1 (xx) 1976-12-31
ES394915A1 (es) 1974-12-16
CH550140A (de) 1974-06-14
RO59112A (xx) 1976-01-15
AT304475B (de) 1973-01-10
CS170528B2 (xx) 1976-08-27
RO59209A (xx) 1976-01-15
RO59211A (xx) 1976-01-15
RO60111A (xx) 1976-06-15
FR2059551A1 (xx) 1971-06-04
BG17750A3 (bg) 1973-12-25
ES394916A1 (es) 1974-12-16
CH536812A (de) 1973-06-29
RO56318A (xx) 1974-09-01
CS170530B2 (xx) 1976-08-27
ES394919A1 (es) 1974-12-01
RO60112A (xx) 1976-08-15
NL169874C (nl) 1982-09-01
DE1937477B2 (de) 1979-08-02
JPS5238556B1 (xx) 1977-09-29
BG17508A3 (bg) 1973-11-10
ES394918A1 (es) 1974-12-01
PL90029B1 (xx) 1976-12-31
YU254675A (en) 1979-04-30
ES394914A1 (es) 1974-12-01
JPS5210861B1 (xx) 1977-03-26
CS170529B2 (xx) 1976-08-27
CS170526B2 (xx) 1976-08-27
BG18852A3 (bg) 1975-03-20
PL90030B1 (xx) 1976-12-31
CH575376A5 (xx) 1976-05-14
YU34113B (en) 1978-12-31
AT303706B (de) 1972-12-11
CH536810A (de) 1973-06-29
AT304474B (de) 1973-01-10
GB1314896A (en) 1973-04-26
PL90038B1 (xx) 1976-12-31
DE1937477A1 (de) 1971-02-04
CS170531B2 (xx) 1976-08-27
CH550139A (de) 1974-06-14
DK140281C (xx) 1979-12-10
ES394917A1 (es) 1974-12-01
PL90027B1 (xx) 1976-12-31
BE753774A (fr) 1971-01-22
ES382014A1 (es) 1973-06-16
PL90025B1 (xx) 1976-12-31
CS170532B2 (xx) 1976-08-27

Similar Documents

Publication Publication Date Title
DK134984B (da) Analogifremgangsmåde til fremstilling af alfa-alkylaminopropiophenoner eller syreadditionssalte heraf.
DK130921B (da) Analogifremgangsmåde til fremstilling af phenethylaminderivater eller syreadditionssalte deraf eller racemater eller optiske antipoder deraf.
DK131029B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-alkylaminopropaner eller syreadditionssalte deraf.
DK129447B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-sek.-alkylaminopropaner eller syreadditionssalte heraf.
DK139717B (da) Analogifremgangsmåde til fremstilling af beta-aryl-2-aminoalkoxystyroler eller syreadditionssalte heraf.
DK140281B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-cycloalkylaminopropaner eller syreadditionssalte heraf.
DK136527B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive p-alkoxyfenoxypropanolaminer eller syreadditionssalte deraf.
DK122133B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive substituerede 3-alkoxythianaphthen-2-carboxamider eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK136526B (da) Analogifremgangsmåde til fremstilling af substituerede naphthylalkylaminer eller syreadditionssalte deraf.
DK121512B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive substituerede 5-phenyl-6,7-benzomorphaner eller syreadditionssalte deraf.
DK124081B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive piperazinderivater eller syreadditionssalte deraf.
DK129577B (da) Analogifremgangsmåde til fremstilling af phenacetylguanidiner eller syreadditionssalte deraf.
DK125639B (da) Analogifremgangsmåde til fremstilling af racemisk eller optisk aktivt 1-(2-nitrilophenoxy)-2-hydroxy-3-ethylaminopropan eller syreadditionssalte heraf.
DK139582B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive benzocycloheptaisoquinolin-forbindelser eller syreadditionssalte deraf.
DK131988B (da) Analogifremgangsmåde til fremstilling af optisk aktive eller racemiske 1-aryloxy-2-hydroxy-3-isopropylamino-propaner eller syreadditionssalte heraf.
DK130582B (da) Analogifremgangsmåde til fremstilling af racemiske blandinger eller optisk aktive isomere af 5-cyclohexyl-1-indancarboxylsyreforbindelser.
DK129235B (da) Fremgangsmåde til fremstilling af racemiske eller optisk aktive quinolinderivater eller syreadditionssalte deraf.
DK125472B (da) Analogifremgangsmåde til fremstilling af pyrimidopyridazinderivater eller syreadditionssalte deraf.
DK129454B (da) Analogifremgangsmåde til fremstilling af ergonorcornin eller syreadditionssalte deraf.
DK130958B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropaner eller fysiologisk tålelige syreadditionssalte heraf.
DK129699B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 9,10-dihydro-9,10-ethano-anthracener eller syreadditionssalte deraf.
DK131727B (da) Analogifremgangsmåde til fremstilling af oxazinobenzoxaziner eller syreadditionssalte deraf.
DK129718B (da) Analogifremgangsmåde til fremstilling af tiazolino-pyrimidin-5-oner eller deres syreadditionssalte eller de tilsvarende optisk aktive forbindelser.
DK131470B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive thiazolino-pyrimidin-5-on derivater eller syreadditionssalte deraf.
DK132551B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive carbamoylalkoxyphenoxyisopropanolaminderivater eller syreadditionssalte deraf.